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Background: Acute appendicitis is the most common surgical emergency in children. Despite this, there is no core
outcome set (COS) described for randomised controlled trials (RCTs) in children with appendicitis and hence no
consensus regarding outcome selection, definition and reporting. We aimed to identify outcomes currently
reported in studies of paediatric appendicitis.
Methods: Using a defined, sensitive search strategy, we identified RCTs and systematic reviews (SRs) of treatment
interventions in children with appendicitis. Included studies were all in English and investigated the effect of one
or more treatment interventions in children with acute appendicitis or undergoing appendicectomy for presumed
acute appendicitis. Studies were reviewed and data extracted by two reviewers. Primary (if defined) and all other
outcomes were recorded and assigned to the core areas ‘Death’, ‘Pathophysiological Manifestations’, ‘Life Impact’,
‘Resource Use’ and ‘Adverse Events’, using OMERACT Filter 2.0.
Results: A total of 63 studies met the inclusion criteria reporting outcomes from 51 RCTs and nine SRs. Only 25
RCTs and four SRs defined a primary outcome. A total of 115 unique and different outcomes were identified. RCTs
reported a median of nine outcomes each (range 1 to 14). The most frequently reported outcomes were wound
infection (43 RCTs, nine SRs), intra-peritoneal abscess (41 RCTs, seven SRs) and length of stay (35 RCTs, six SRs) yet
all three were reported in just 25 RCTs and five SRs. Common outcomes had multiple different definitions or were
frequently not defined. Although outcomes were reported within all core areas, just one RCT and no SR reported
outcomes for all core areas. Outcomes assigned to the ‘Death’ and ‘Life Impact’ core areas were reported least
frequently (in six and 15 RCTs respectively).
Conclusions: There is a wide heterogeneity in the selection and definition of outcomes in paediatric appendicitis,
and little overlap in outcomes used across studies. A paucity of studies report patient relevant outcomes within the
‘Life Impact’ core area. These factors preclude meaningful evidence synthesis, and pose challenges to designing
prospective clinical trials and cohort studies. The development of a COS for paediatric appendicitis is warranted.
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Acute appendicitis is the most common surgical emer-
gency in children [1]. The lifetime risk of developing ap-
pendicitis is 7-8 % with a peak incidence in the early
teenage years. Traditionally, appendicectomy has been
the gold standard treatment for acute appendicitis. This
requires an inpatient stay, a surgical operation requiring
general anaesthesia, and exposure to potential complica-
tions not only of the disease but also surgery. Whilst the
majority of children recover from acute appendicitis, the
disease carries a mortality of 0.08-0.31 per 1,000 cases in
children [2].
In recent years, there has been growing interest in alter-
natives to appendicectomy. In particular, non-operative
treatment of appendicitis, with antibiotics alone, has been
proposed as a potential treatment. A small number of ran-
domised controlled trials (RCTs) in adults [3–5] and, more
recently, children [6, 7] suggest that antibiotic treatment
may be a valid alternative to appendicectomy. However
there is currently insufficient data to justify its widespread
use. Prior to performing further efficacy studies of the
treatment of appendicitis in children, it is imperative to
identify the most relevant outcome measures for inclusion
in the design of comparative studies. This is of particular
importance when evaluating a novel treatment approach
since the outcomes of importance may differ from those
commonly reported with traditional therapies.
Core outcome sets (COS) have been proposed as a
means of standardizing outcome selection, measurement
and reporting in healthcare research and in clinical trials
in particular [8, 9]. The development of a COS and its
adoption by researchers is intended to help avoid incon-
sistencies in outcome selection, measurement and report-
ing that may otherwise exist. The lack of a COS may
result in (i) important outcomes being overlooked or
omitted in study design, (ii) inconsistent definitions or
measurement techniques being used across studies and,
(iii) omission of important outcomes from reports (report-
ing bias) [8]. Selecting outcomes that are important to a
range of stakeholders is important if research is to be
meaningful and relevant. If trials do not adopt an estab-
lished COS they risk selecting suboptimal outcomes and
are unlikely to contribute usable information [10]. The
use of outcomes within a COS should also improve evi-
dence synthesis across multiple studies (for example,
meta-analysis) by removing inconsistencies in outcome se-
lection, definition and reporting.
A review of the relevant literature and electronic
resources failed to identify a COS for children with appen-
dicitis. As the first stage of a process to develop a COS, we
designed a study to determine which outcomes are
currently reported in RCTs and systematic reviews (SRs)
investigating treatment interventions in children (≤18
years) with acute appendicitis.Methods
This review was performed in accordance with the
PRISMA guidelines for systematic reviews (see Additional
file 1 for compliance details) [11] and according to a
defined protocol (provided as Additional file 2).
Study selection criteria
Studies from the existing literature were selected in
order to address our specific research question using the
following criteria.
Types of studies
We included systematic reviews of RCTs with or without
meta-analysis, and randomised controlled trials.
Types of intervention
Any medical or surgical intervention intended as
treatment, or as a component of the treatment, of pa-
tients ≤18 years of age (that is, children, infants or
babies) with acute appendicitis was included. For the
purposes of this review, we did not apply a specific
definition of acute appendicitis, for example, one
based on diagnostic imaging or pathology findings,
because not all participants of individual studies had
diagnostic imaging or pathology on a surgical speci-
men. This is consistent with contemporary surgical
practice. Rather, we included studies on the basis that
the population being reported had a diagnosis of
acute appendicitis, regardless of how it was defined in
the individual study.
Types of participants
Participants were children aged ≤18 years with acute
appendicitis.
Exclusion criteria
Studies in which the purpose of the intervention was for
symptom control rather than treatment of disease in-
cluding analgesic interventions and interventions to treat
nausea and vomiting, studies comparing one or more
diagnostic techniques, RCTs that reported a population
that included any patient over 18 years of age without a
subgroup analysis containing only children ≤18 years,
studies that included any patient with a diagnosis other
than acute appendicitis, studies reported in abstract
form only such as conference proceedings, and any
study that was not written in English were all excluded.
Interim reports of a study for which the final report was
included were excluded as were prior versions of SRs for
which the review had been more recently updated and
was included.
Search strategy Searches were conducted by an aca-
demic health information specialist (CN) in April 2014
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22 2014 and including the “In-process & Other Non-
Indexed” segment), Embase (1947 to 2014 Week 16) and
Cochrane Central Register of Controlled Trials -
CCRCT (1991 - 22 April 2014). Database specific subject
headings were selected for the concepts of appendicitis,
children and randomised controlled trial study design.
Database subject headings were exploded, when applic-
able, to include narrower terms. Free text word searches
were generated for all of the concepts using the database
‘Used For’ terms. In all databases, adjacency operators
and truncation symbols were used in text word searches
when appropriate to capture variations in phrasing and
expression of terms. All synonymous terms were com-
bined first using the Boolean “OR.” The three distinct
concepts related to intervention, population, and study
design were combined with the Boolean “AND” in
MEDLINE and Embase. In CCRCT, only the concepts of
appendicitis and children were searched and combined
with “AND.” No language or date restrictions were ap-
plied. A detailed search strategy for MEDLINE is de-
scribed in Appendix 1. We limited our search to the
three electronic databases and did not search other
sources with the exception of searching the reference
lists of SRs for RCTs that were not identified by our lit-
erature search.
Study selection
Two reviewers (NJH and MZK) independently assessed
the titles and abstracts of all identified citations. Full-
text articles were retrieved if either reviewer considered
the citation potentially relevant with a low threshold for
retrieval. Full texts of selected studies were then critic-
ally reviewed to assess eligibility. Reasons for exclusion
of studies were recorded. The bibliographies of studies
included for full-text review were also evaluated for add-
itional relevant references. The final set of studies which
was included in the systematic review was determined
by consensus (between NH and MZK) with any dis-
agreements resolved by a third reviewer (SE).
Data extraction
Data were extracted independently and in duplicate by
two reviewers (NJH and MZK) who then reviewed the
extracted data together to ensure accuracy. Disagree-
ments were resolved by a third reviewer (SE) when ne-
cessary. The following data were extracted from each
study: study design (RCT or SR), year of study, region of
origin, sample size, use of a primary outcome, all out-
comes reported, and provision of a definition of each
outcome. An outcome was included as reported whether
it was included in the methods section, results section,
or both. A study was deemed to use a primary outcome
if the words ‘primary outcome’ were stated in the report,if data for a particular outcome were used to generate a
sample size for a study, or if the stated aim of a study
was to investigate the effect of an intervention on a sin-
gle specific outcome or single defined composite
outcome.
Assessment of the similarity of outcomes
We anticipated diversity in the terminology used to re-
port outcomes and therefore grouped similar outcomes.
We identified outcomes that seemed similar or of a
similar theme despite differing definitions used across
studies and assigned an appropriate term to them. For
instance, the outcomes ‘fever on post-operative day 3’,
‘duration of post-operative fever’ and ‘episodes of fever’
were all included in the term ‘post-operative fever’. We
defined an additional outcome term of ‘other single out-
come’ when an outcome was reported by a single study
that could not naturally be mapped to any other out-
come term.
Where a composite outcome was used we considered
each individual component of the composite individually
and included each in analysis but excluded the compos-
ite outcome from analysis. For example the outcome
‘surgical site infection’ was excluded unless its compo-
nents of ‘wound infection’ and ‘intra-abdominal abscess’
were not reported separately.
Assignment of outcome terms to core areas
Each individual outcome term was assigned to one of
five core areas identified from the OMERACT Filter 2.0
[12]. The OMERACT Filter 2.0 is a framework devel-
oped to ensure that a full breadth of outcomes is re-
ported by RCTs during the development of a COS. The
OMERACT Filter 2.0 includes the four core areas of
‘Death’, ‘Pathophysiological Manifestations’, ‘Life Impact’,
and ‘Resource Use’. It further recommends that ‘Adverse
Events’ are reported across all core areas. For the pur-
poses of this review, we included ‘Adverse Events’ as a
fifth core area. Terms were mapped to core areas inde-
pendently by two reviewers (NJH and MZK), and dis-
crepancies were resolved by a third reviewer (SE) as
necessary. We then determined the number of studies
that provided an outcome within each core area and the
number of core areas covered by each individual study
in this review.
Data synthesis
The total number of studies identified and included and
the number of different outcomes identified in both
RCTs and SRs were counted and reported separately to
avoid double counting of outcomes. Although some of
the RCTs do contribute to some of the SRs, our descriptive
reporting means that this does not impact our findings.
The number of outcome terms, variations in definition for
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study are reported and illustrated graphically. Finally, we
identified the number of outcome terms assigned to each
core area and the number of core areas covered by each
included study. All these data are reported descriptively
with appropriate summary measures for non-parametric
data. Since we did not capture quantitative outcome data
from individual studies, rather which outcomes were
selected and reported, it is inappropriate to assess
heterogeneity between studies formally using an I2
statistic or similar.
Results
Identification and description of included studies.
A flow diagram detailing article selection is shown
in Fig. 1. Our search yielded a total of 1,728 articles
(620 from Medline, 633 from EMBASE, and 475 from
CCRCT). Screening of 929 non-duplicate titles and
abstracts identified 201 citations to undergo full text
review. One study [13] was excluded as it reported
interim results of a trial that was subsequently re-
ported in full and included in this review [14]. Early
versions of two SRs were excluded [15–18] as they
were prior versions of subsequently updated (and
included) SRs [19, 20].Fig. 1 PRISMA article selection flow diagramA total of 63 articles met the specified inclusion cri-
teria and were included in this review. Nine of these
were SRs, with or without meta-analysis, including two
Cochrane reviews [19, 20]. The remaining 54 published
articles reported outcomes from 51 RCTs, as three of
the RCTs provided data for two articles each. Myers et
al. [21] reported cost-related outcomes of the trial for
which clinical outcomes were separately reported by
Blakely et al. [22]. Schurman et al. [23] reported patient
and parent quality of life outcomes of the trial for which
clinical outcomes were reported by St Peter et al. [24].
Gasior et al. [25] reported cosmetic outcomes of the trial
for which the clinical outcomes were reported by St
Peter et al. [26]. For the purposes of analysis, the data
arising from these three supplementary articles were
amalgamated with the clinical outcomes. We therefore
present outcomes reported in 51 RCTs and 9 SRs.
The characteristics of included studies are found in
Table 1. Years of publication were between 1973 and 2013
for RCTs and between 2005 and 2013 for SRs. The median
total sample size for each RCT was 100 children (range 25
to 1083). The region of origin for the RCTs included
North America (n = 18), Europe (n = 22), Asia (n = 8),
Africa (n = 1), Australasia (n = 2) and Central America
(n = 1). The interventions investigated in each study fell
Table 1 Characteristics of included studies
First Author Year Intervention type Study type Region of origin Sample size Age of included population
Haller Jr, [37] 1973 Surgical RCT NA 43 0 to 14 years
Bates [38] 1974 Antibiotic RCT Europe 38 0 to 9 years
Fowler [39] 1975 Antibiotic RCT Australasia 69 ‘children’
Sherman [40] 1976 Surgical RCT NA 79 13 month to 16 years
Giacomantonio [41] 1982 Antibiotic RCT NA 42 ‘pediatric age range’
Hutchinson [42] 1983 Antibiotic RCT Europe 133 16 month to 15 years
King [43] 1983 Antibiotic RCT NA 64 <18 years
Foster [14] 1987 Antibiotic RCT Europe 100 5 to 14 years
Gutierrez [44] 1987 Antibiotic RCT Europe 100 <10 years
Thomson [45] 1987 Antibiotic RCT Europe 84 4 to 13 years
McAllister [46] 1988 Antibiotic RCT Europe 401 ‘children’
Schmitt [47] 1989 Antibiotic RCT Europe 64 6 months to 15 years
Kooi [48] 1990 Antibiotic RCT Asia 100 <13 years
Meller [49] 1991 Antibiotic RCT NA 59 2 to 15 years
Pokorny [50] 1991 Antibiotic RCT NA 95 2 to 12 years
Schropp [51] 1991 Antibiotic RCT NA 97 <18 years
Kizilcan [52] 1992 Antibiotic RCT Europe 100 0 to 15 years
Tsang [53] 1992 Surgical RCT Asia 63 2 to 12 years
Uhari [54] 1992 Antibiotic RCT Europe 218 2.5 to 16.8 years
Banani [55] 1995 Antibiotic RCT Asia 246 4 to 15 years
Soderquist-Elinder [56] 1995 Antibiotic RCT Europe 544 ‘children’
Toki [57] 1995 Surgical RCT Asia 53 2 to 14 years
Lejus [27] 1996 Surgical RCT Europe 63 8 to 15 years
Ciftci [58] 1997 Antibiotic RCT Europe 200 1 to 16 years
Banani [59] 1999 Antibiotic RCT Asia 1083 4 to 15 years
Gorecki [60] 2001 Antibiotic RCT Europe 152 ‘children’
Lavonius [61] 2001 Surgical RCT Europe 43 7 to 15 years
Lintula [62] 2001 Surgical RCT Europe 61 4 to 15 years
Rice [63] 2001 Antibiotic RCT NA 26 5 to 18 years
Shalaby [64] 2001 Surgical RCT Africa 150 7 to 14 years
Lintula [65] 2002 Surgical RCT Europe 25 4 to 15 years
Little [66] 2002 Surgical RCT NA 129 1 to 16 years
Tander [67] 2003 Surgical RCT Europe 140 Mean 7.1 year
Lintula [68] 2004 Surgical RCT Europe 87 4 to 15 years
Oka [69] 2004 Surgical RCT NA 517 Mean 10.7 years
Snelling [70] 2004 Antibiotic SR NA 2284 <21 years
Andersen [19] 2005 Antibiotic SR NA NR ‘children’
Henry [71] 2005 Surgical SR NA 107 ‘children’
Schneider [72] 2005 Antibiotic RCT Europe 27 Mean 10.3 years
Aziz [73] 2006 Surgical SR NA 6,477 ‘children’
Malik [34] 2007 Surgical RCT Asia 120 3 to 18 years
Padankatti [74] 2008 Surgical RCT Asia 30 2 to 14 years
St Peter [1] 2008 Antibiotic RCT NA 100 Mean 8.6 years
Fraser [75] 2010 Antibiotic RCT NA 102 Mean 9.9 years
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Table 1 Characteristics of included studies (Continued)
Pauniaho [76] 2010 Surgical RCT Europe 198 4 to 18 years
Saha [77] 2010 Surgical RCT Asia 60 <12 years
Sauerland [20] 2010 Surgical SR NA 542 ‘children’
St Peter[24] 2010 Surgical RCT NA 40 <18 years
Blakely [22] 2011 Surgical RCT NA 131 <18 years
Perez [78] 2011 Antibiotic RCT CA 100 2 to 12 years
Romero [35] 2011 Antibiotic RCT Europe 49 5 to 15 years
Schurman [23] 2011 Surgical RCT NA 40 <18 years
St Peter [26] 2011 Surgical RCT NA 360 <18 years
Esposito [79] 2012 Surgical SR NA 123,628 0 to 18 years
Markar [80] 2012 Surgical SR Europe 107,624 ‘children’
Myers [21] 2012 Surgical RCT NA 131 <18 years
St Peter [81] 2012 Surgical RCT NA 220 <18 years
Yu [82] 2013 Surgical RCT Australasia 190 8 to 14 years
Dalgic [83] 2013 Antibiotic RCT Europe 107 3 months to 17 years
Gasior [25] 2013 Surgical RCT NA 198 <18 years
Li [84] 2013 Surgical SR Asia 873 children >1 year
Nataraja [85] 2013 Surgical SR Europe 22,060 <18 years
Perez [86] 2013 Surgical RCT NA 50 2.9 to 15.7 years
CA Central America, NA North America, NR not reported, RCT randomised controlled trial, SR systematic review
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type, route of administration, or duration; (B) investigation
of a type of surgical intervention, including type and tim-
ing of wound closure, use of a peritoneal drain, type of
peritoneal access (for example, open, laparoscopic, single
incision laparoscopic), timing of appendicectomy, and
type of insufflation gas during laparoscopic appendec-
tomy. A total of 28 RCTs fell into category A and 23 into
category B. Two systematic reviews were related to anti-
biotic use (category A) and seven to type of surgical inter-
vention (category B).
Description of outcomes in RCTs
A total of 115 different unique outcomes were identified
in the 51 RCTs. One hundred and six of these outcomes
were mapped to the 38 terms shown in Fig. 2, and 12
outcomes were mapped to the additional term ‘other
single outcome’. Each RCT reported a median of nine
“unmapped” outcomes (range 1-14). The most fre-
quently reported outcome was wound infection, which
was reported in 43 RCTs (84.3 %) and was the primary
outcome or a component of a composite primary out-
come in nine RCTs (17.6 %). Figure 3a shows the distri-
bution of primary and secondary outcome terms across
individual RCTs. A primary outcome was identified in
26 RCTs (50.9 %). In addition to a wide range in number
of outcomes reported in each study, there was great het-
erogeneity in terms reported across studies. For example
only 25 of the 51 (49 %) RCTs reported all of the threemost frequently reported terms (wound infection, ab-
scess formation and length of stay). Definitions are
shown in Table 2 for outcomes identified in RCTs for
which there may be variability dependent on the defin-
ition. We identified multiple definitions used for many
outcomes, apparently leading to different occurrence
frequencies of “similar outcomes” across studies. For
wound infection, the most frequently reported outcome,
there were a total of 11 different definitions identified in
43 RCTs, 31 of which reported no definition. Finally,
work was undertaken to ascertain whether any substan-
tial changes occurred in the reported outcomes over the
period of publication covered by this study (1973-2013),
but none was found.Description of outcomes in systematic reviews
A total of 31 different outcomes were identified in the
nine SRs and were mapped to the same terms shown in
Fig. 2. The most frequently reported outcome in SRs
was also wound infection, which was reported in all SRs.
The distribution of primary and secondary outcome
terms across individual SRs is shown in Fig. 3b. A pri-
mary outcome was identified in four SRs, including a
composite primary outcome in two. Definitions of out-
comes used in SRs are shown in Table 3. Outcomes were
generally poorly defined in SRs, which often replicated
the definition used in individual studies contributing to
the review.
Fig. 2 Assignment of outcome terms to core areas. WCC white cell count, CRP C-reactive protein, PROM patient reported outcome measure
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Thirty-seven of the 38 outcome terms were assigned
to core areas defined by OMERACT Filter 2.0; the
outcome term ‘other single outcome’ could not be
mapped due to its definition and inherent heterogen-
eity. The assignment of outcome terms to core areas
is shown in Fig. 2. The core area populated most
heavily was ‘Adverse Events’ (n = 13 outcome terms),
followed by ‘Life Impact’ (n = 10 outcome terms).
With the exception of the core area ‘Death’, the core
area of ‘Pathophysiological Manifestations’ was popu-
lated least (n = 5 outcome terms).
All RCTs and SRs reported at least one outcome
assigned to the ‘Adverse Event’ core area. The median
number of core areas to which outcome terms were
assigned in both RCTs and SRs was three. Two RCTs re-
ported outcomes assigned to just one core area, and only
one RCT [27] reported outcomes assigned to all five
core areas (Fig. 4a). For SRs, two studies reported out-
comes in just one core area, whereas no SR reported
outcomes in all five core areas (Fig. 4b). With the excep-
tion of death (reported in 6 RCTs and no SRs) the core
area ‘Life Impact’ was reported least frequently (15 RCTs
and 3 SRs).
Discussion
We have analysed outcome reporting from a large num-
ber of RCTs and SRs relating to the treatment of acuteappendicitis in children. The principal findings of our re-
view are 1) a wide heterogeneity of outcomes reported
between individual studies, 2) the lack of a standardised
definition for commonly reported outcomes (including
absence of any definition), 3) little overlap in outcomes
used across studies, and 4) a relative paucity of studies
reporting patient relevant outcomes within the ‘Life Im-
pact’ core area. These findings have implications for the
validity of comparisons made between individual RCTs,
not only within meta-analyses, but also for the practising
surgeon when making a best practice judgement based
on best available evidence. Our findings also suggest that
patient or parent involvement in defining appropriate
outcomes for this condition has been limited. The ma-
jority of outcomes are highly clinically focused, suggest-
ing that they have been proposed by and considered
important to, clinicians. A similar phenomenon was
identified by a recent review of studies reporting COS
development [10]. Overall, our study provides justifica-
tion for the development of a COS for acute appendicitis
in children. It also highlights the need for such an out-
come set to use standardised definitions of included out-
comes and for the involvement of multiple key
stakeholder groups, particularly patients and parents, in
both identifying candidate outcomes and within any
consensus process leading to definition of a COS. In line
with the principles of COS development, such a COS for
paediatric appendicitis has the capacity to improve the
Fig. 3 a Outcome matrix of 38 outcome terms for 51 RCTs b. Outcome matrix of 20 outcome terms reported in 9 systematic reviews (SRs)
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Table 2 Variation in definition of outcomes in randomised
controlled trials
Definition of wound infection (n = 43)
Presence of pus in the wound or wound pain, tenderness or
erythema of sufficient magnitude to interfere with the patients
well-being or to prolong hospital stay or to require readmission
for wound infection [41]
Discharge of pus from the wound [14, 42, 47]
Purulent material which drained either spontaneously or by
surgical incision [43]
Pus or erythema in the wound [49]
Presence of gross purulent discharge with or without positive
bacterial culture [53]
Purulent discharge or positive culture from wound [55]
Suppuration confirmed by spontaneous wound rupture,
debridement or incision [56]
Peri-incisional cellulitis or seropurulent wound drainage,
whether culture positive or not [60]
Local signs of inflammation plus positive bacterial culture [65]
Clinical wound evaluation score on post-operative day 1, 2
and 7 [76]
No formal definition (n = 31)
Definition of intra-abdominal/peritoneal abscess (n = 42)
Clinical symptoms plus laboratory findings of inflammation
plus a positive ultrasound examination [65]
Abscess within the abdominal cavity diagnosed at operation
or by rectal examination, x-ray or ultrasound [56]
Collections of purulent material which drained either
spontaneously or by surgical incision [43]
Deep abscess [42]
No formal definition (n = 38)
Definition of post-operative fever (n = 16)
Duration of fever (maximum daily rectal temperature
>101 °F) [43]
Duration of fever [47]
Incidence of post-op fever (rectal >101 °F) during
first 3 post-operative days [49]
Duration of fever (>100 °F) [50]
Duration of fever (>101 °F) [51]
Mean daily temperature; incidence fever (>37.5 °C)
on third post-operative day [54]
Duration of fever (>38.0 °C) [55]
Duration of fever (>37.0 °C) [57, 58]
Temperature on first post-operative day [60]
Incidence of persistent fever (>38.5 °C for >3 days) [63]
Incidence of post-operative fever [66]
Maximum daily temperature for first five post-operative
days [1, 75, 83]
Temperature on day 4 of treatment; percentage afebrile
by day 7 of treatment [78]
Table 2 Variation in definition of outcomes in randomised
controlled trials (Continued)
Definition of post-operative leucocytsis (n = 8)
Duration of white cell count (WCC) >12,500/cm3 [43]
Pre-discharge WCC [51]
WCC on days 4 and 8 of treatment [78]
Duration of WCC >10 x 109/L [58]
Resolution of leukocytosis [60]
Time to return to normal WCC [63]
Trend of WCC reduction [55]
WCC on post-operative days 1 and 2 [76]
Definition of time away from normal activity (n = 4)
Return to school [40, 65]
Resumption of normal activity [66]
Time away from normal activities (a combination of objective
time periods (hospital length of stay, outpatient status with
central venous catheter, and receiving intravenous antibiotics)
and more subjective time periods (for example, outpatient
with symptoms that limit activity)) [22]
Definition of time away from full activity (n = 3)
Able to do full physical activity at 1 and 4 weeks [61]
Return to sport activities [65]
Days to full activity [26]
Definition of cosmesis (n = 3)
Visual cosmesis score on eighth post-operative day [34]
Parental dissatisfaction with cosmetic result at 10 and
90 days; assessment by surgeon (mean of two blinded
assessors) using a visual analogue scale at 90 days [35]
Patient scar assessment questionnaire (validated in adults)
at 6 weeks and 18 months [25]
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benefits for researchers, clinicians and patients.
This study suggests that the outcomes judged to be of
greatest relevance to clinicians and researchers are
wound infection and intra-abdominal abscess formation.
At least one of these outcomes was reported in 94 % of
RCTs and all SRs. Despite this, only a minority of each
type of study used a standardised definition for either
outcome. A wide variety of definitions were also used
for other frequently reported outcomes. The issue of a
lack of definition of commonly reported outcomes is not
unique to paediatric appendicitis. Previous studies of
other health conditions have highlighted variability in
definitions [28–30] including one study that identified
56 separate definitions for the same outcome across a
review of 97 studies [31]. The lack of definition and vari-
ation in definitions across a single outcome severely
hampers attempts to compare results between studies. A
precise and standardised definition of any outcome
measure is one of the key principles underlying selection
of an outcome within a COS.
Table 3 Variation in definition of outcomes in systematic reviews
Definition of wound infection (n = 9)
Discharge of pus from the wound [19, 71]
Wound infection within the first month of
surgery as a direct result of the initial
operation [80]
No formal definition (n = 6)
Definition of intra-abdominal abscess (n = 7)
Postoperative intra-abdominal abscess
(persistent pyrexia without any other
focus, after operation, palpable mass
in the abdomen or discharge of pus
from the rectum) [19]
No formal definition (n = 6)
Definition of post-operative fever (n = 2)
Duration of fever [70]
Post-operative fever [73]
Definition of leucocytosis (n = 1)
Duration of leukocytosis [70]
Definition of time to normal activity (n = 1)
Return to normal activity [20]
Definition of time to full activity (n = 1)
Return to full activity; return to
sports [20]
Definition of cosmesis (n = 1)
Cosmesis measured on visual
analogue scale [20]
Fig. 4 a Distribution of core areas to which outcome terms were
assigned in RCTs. b Distribution of core areas to which outcome
terms were assigned in SRs
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over half of SRs) did not define a primary outcome. It is
therefore not possible to determine which outcome re-
searchers considered most important to measure for
these studies. Further consequences of the lack of pri-
mary outcome are the possibility of reporting bias since
it is not known whether only statistically significant out-
comes are reported and that these studies may have
lacked sufficient power to determine effect of treatment
intervention.
We identified further methodological inconsistencies
that may also act as a source of bias within RCTs. For
instance, a number of RCTs stated that an outcome
would be measured in the methods section but it was
then never actually reported. Whilst we do not believe
this type of inconsistency has impacted our results be-
cause we specifically included outcomes mentioned in
either ‘methods’ or ‘results’ section of each report, this
observation clearly reflect reporting bias within individ-
ual studies. Other methodological issues encountered
within RCTs included randomization techniques that
may be subject to lack of concealment. Whilst some re-
views of outcome reporting have included an assessment
of the methodological quality of RCTs to identify poten-
tial sources of bias [29], we did not complete a full
methodological assessment for each study included in
our review. We do not believe that other biases that may
exist within RCTs have influenced the primary objective
of our study, namely to identify outcomes reported by
existing RCTs and SRs. The exception to this is report-
ing bias for which we used a specific strategy to identify
outcomes that were planned to be reported as well as
those that actually were. As a result we feel the chances
that we have missed important outcomes are minimal.
In recent years, the COMET (Core Outcome Measures
in Effectiveness Trials) initiative [32] has strongly sup-
ported the development of core outcome sets to stand-
ardise outcome definitions and measurement for studies
that assess the efficacy of a treatment. The expectation is
that a trial investigating treatment of a condition should
always measure and report (as a minimum) each outcome
within a COS where one exists for that condition. Further
guidance from groups such as OMERACT [12, 33] has
supported the importance of reporting a wide breadth of
outcomes across a number of core areas to ensure that
each COS is relevant for multiple stakeholder groups and
in particular the patient. Whilst all five core areas were
fulfilled with outcomes in our review, outcomes which
may be of greater relevance to patients or parents, or pro-
vide an assessment of outcome from a patient or parental
perspective in the ‘Life Impact’ core area were rarely re-
ported. For example, only three of the 23 RCTs relating to
type of surgical intervention reported any marker of
cosmesis as an outcome [26, 34, 35], and only one RCT
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ment tool [23]. Based on our experience in this review,
the OMERACT filter 2.0 likely acts as a useful framework
for researchers to ensure that all core areas are fulfilled
when developing a COS and designing a RCT.
However, the OMERACT Filter 2.0 may have some
limitations. It was developed primarily for designing tri-
als within the field of rheumatology [12] and has subse-
quently been proposed as an appropriate framework for
other fields [33]. Hence there may be specialty-specific
or age-group specific factors that affect the suitability of
the filter for other fields. In assigning outcome terms to
OMERACT core areas, we encountered several examples
where an outcome term could potentially be assigned to
more than one core area. For example, hospital length of
stay could be considered in the context of (ongoing)
‘Pathophysiological Manifestations’, or within ‘Resource
Use’ or ‘Life Impact’. We did not identify any outcome
terms that could not be readily assigned to any of the
OMERACT core areas but would urge those developing
core outcome sets to be critical in their assignment of
outcomes to ensure that all core areas are genuinely cov-
ered in any COS.
In addition to proposing core areas, the OMERACT
framework goes further, identifying essential characteris-
tics of outcome measures within a COS which should be
‘truthful’, ‘discriminative’ and ‘feasible’ [12]. The lack of
definitions of outcomes we have identified would clearly
not pass these criteria. It is essential that this is
addressed in the development of a COS. Whilst it is pos-
sible that the reason important core areas such as ‘Life
Impact’ have been relatively ignored in existing studies is
because of a lack of reliable and valid measures, we sus-
pect this it is not the case and that a focus on clinician
relevant outcomes is a more likely explanation.
The principal strengths of this systematic review are
the extensive literature searches in multiple bibliograph-
ical databases over a long time period. We captured a
wide range of outcomes with a variety of definitions.
Whilst a limitation of our methodology to include only
RCTs and SRs means that it is possible that other out-
comes reported in other types of study have been
missed, we are confident that our methodology has en-
abled us to capture outcomes that researchers and clini-
cians consider important. The main weakness of our
study is that our search for outcomes has been limited
to those reported in the existing literature. We are un-
able to comment on outcomes that may not have been
reported in the existing literature or are important to
other stakeholder groups, in particular patient and par-
ents, but also other health professionals such as nurses
and family doctors. The importance of engaging patients
and parents in research and in particular in defining out-
comes of importance is being increasingly recognized.Only by ensuring that patients and parents are involved
in determining which outcomes should be measured can
we be confident that treatment interventions are investi-
gated in a way that is relevant to the target population.
This aspect will be key in developing a COS. Outcomes
may also not have been reported in RCTs and SRs due to
selective reporting bias, a relatively common phenomenon
[36]. While our systematic review highlighted the hetero-
geneity of outcome reporting, outcome reporting bias has
a more detrimental effect on quantitative meta-analyses to
establish benefit (or harm) of an intervention, which was
not the objective of our current study.
Although acute appendicitis is the most common ab-
dominal surgical emergency in children, and is one of
the few areas in paediatric surgery that has been the sub-
ject of multiple RCTs, there is no COS for the condition.
Existing outcomes are heavily biased towards clinician
and researcher areas of interest rather than patient/par-
ent relevant factors and do not use standardised defini-
tions. This study supports our commitment to develop a
COS for acute appendicitis in children to ensure that
outcomes measured in future studies of existing and
novel therapies are relevant to multiple stakeholder
groups and that studies can be compared, combined and
contrasted meaningfully. We now intend to complete a
consensus process amongst these stakeholder groups to
develop a COS for acute appendicitis in children consist-
ent with the principles of the OMERACT framework
and for use in future trials of treatment interventions.
Conclusions
There is a wide heterogeneity in the selection and defin-
ition of outcomes in RCTs and SRs of paediatric appen-
dicitis with little overlap in outcomes used across
studies. A paucity of studies report patient relevant out-
comes within the ‘Life Impact’ core area. These factors
impair meaningful evidence synthesis, and pose chal-
lenges to those designing prospective clinical trials and
cohort studies. The commitment to develop a COS for
paediatric appendicitis is justified.
Appendix 1
Search strategy for MEDLINE
Database: Ovid MEDLINE(R) 1946 to Present with
Daily Update, Ovid MEDLINE(R) In-Process & Other
Non-Indexed Citations <April 21, 2014>
Search Strategy:
1. Appendicitis/ (15193)
2. Appendix/ (5012)
3. Appendectomy/ (8492)
4. (appendix or appendicitis or appendicectom* or
appendectom* or "vermiform process*" or "processus
vermiformis").mp. (31995)
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6. exp Randomized Controlled Trials as Topic/
(93075)
7. exp randomized controlled trial/ (371186)
8. meta-analysis/ (47125)
9. meta-analysis as topic/ (13675)
10.cross-over studies/ or double-blind method/ or
random allocation/ or single-blind method/ (232109)
11.(random* or rct*).mp. (891252)
12.(pragmatic adj2 trial*).mp. (735)
13.("meta-analys*" or metaanalys*).mp. (82887)
14."systematic review*".mp. (52825)
15.(medline or embase or lilacs or wos or "web of
science" or scopus or cochrane).ti,ab. (72530)
16.((doubl* or singl* or tripl*) adj2 (blind* or
mask*)).mp. (178525)
17.((cross-over or crossover) adj2 (design* or stud*
or trial*)).mp. (53183)
18.or/6-17 (1028267)
19.5 and 18 (1365)
20.limit 19 to "all child (0 to 18 years)" (555)
21.(infan* or newborn* or new-born* or neonat* or
baby or babies or child* or youth or kid or kids
or toddler* or boy* or girl* or adolescen*
or teen* or juvenile* or p?ediatric*).mp. (3381275)
22.19 and 21 (620)
23.20 or 22 (620)
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